Awan, F., Zawadzki, N., Teschemaker, A., Wojtas, K., Satre, D., Shetty, V., Patel, D., Fam, F., Crowley, R., Shafrin, J. (2025). Budget impact of fixed duration acalabrutinib in combination with venetoclax in previously untreated chronic lymphocytic leukemia patients in the United States. Blood. https://doi.org/10.1182/blood-2025-2627